diabetic retinopathy semaglutide The research on and NAION is conflicting. The concern around is context-dependent. The answer is not a simple yes or no., This is general education only, not personal New study finds semaglutide may

The most commonly reported side effects are gastrointestinal in nature and include: Nausea (affecting up to 20-40% of users, particularly during dose escalation) [5] [1] Vomiting and diarrhoea Constipation Abdominal pain and bloating Reduced appetite (which, whilst therapeutically desired, can be excessive in some individuals) Headache and dizziness Injection site reactions (redness, swelling or itching) These effects are typically most pronounced when initiating therapy or increasing doses, which is why gradual titration is recommended

Lifestyle Support: Medical intervention and lifestyle change together that promotes long-term success

411,412,413,414 This effect is mediated by NAD + -dependent PARPs and SIRT1

By boosting fat metabolism and aiding mitochondrial function, it helps the body respond more effectively to insulin